Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2022 | R33 | CA267226 | CA21-004 | DRAKE, RICHARD R | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids | Active |
2021 | R21 | CA256081 | RFA-CA-20-017 | SWAGER, TIMOTHY M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation | Active |
2020 | R33 | CA240191 | RFA-CA-19-020 | RECHT, MICHAEL | PALO ALTO RESEARCH CENTER | High-Throughput Screening Platform for Cancer Drug Discovery | Active |
2023 | R61 | CA281657 | RFA-CA-22-001 | LUKER, GARY D | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Integrated Imaging Tools for Intercellular Chemokine Signalling | Active |
2023 | R61 | CA278402 | RFA-CA-22-001 | BRAVO CORDERO, JOSE JAVIER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Intersectional genetics-based biosensors for dormant cancer cells | Active |
2022 | R21 | CA267260 | CA21-003 | ARMITAGE, BRUCE A | CARNEGIE-MELLON UNIVERSITY | Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA | Active |
2021 | R21 | CA256082 | RFA-CA-20-017 | BAR-PELED, LIRON | MASSACHUSETTS GENERAL HOSPITAL | Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors | Active |
2023 | R33 | CA281875 | RFA-CA-22-004 | BRUDNO, YEVGENY | NORTH CAROLINA STATE UNIVERSITY RALEIGH | MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells | Active |
2022 | R21 | CA257816 | CA21-003 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Adapting K-MDS to detect KRAS-mutant ctDNA | Active |
2021 | R21 | CA258019 | RFA-CA-20-017 | CHEN, KAI | UNIVERSITY OF SOUTHERN CALIFORNIA | Novel Bisphosphonate PET Probes for Myeloma Bone Disease | Active |
2023 | R33 | CA278392 | RFA-CA-22-002 | KLEIN, ALLON MOSHE | HARVARD MEDICAL SCHOOL | Micro-capsules for versatile multiplexed cytometry | Active |
2022 | R33 | CA261696 | CA21-004 | MERAJVER, SOFIA DIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence | Active |
2021 | R33 | CA247700 | RFA-CA-20-018 | JI, HANLEE P | STANFORD UNIVERSITY | Multimodal iterative sequencing of cancer genomes and single tumor cells | Active |
2022 | R33 | CA267258 | RFA-CA-21-004 | LEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA247744 | RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Universal Sample Multiplexing for Single Cell Analysis | Active |
2023 | R61 | CA278531 | RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R33 | CA251006 | RFA-CA-20-020 | HAUN, JERED BRACKSTON | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic tumor tissue processing platform for single cell diagnostics | Active |
2022 | R21 | CA269099 | RFA-CA-21-003 | YAKOVLEV, VLADISLAV V | TEXAS ENGINEERING EXPERIMENT STATION | Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2022 | R21 | CA272351 | RFA-CA-21-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2023 | R33 | CA281802 | RFA-CA-22-002 | LABAER, JOSHUA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck | Active |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2022 | R21 | CA267245 | RFA-CA-21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2022 | R33 | CA269100 | CA21-004 | CHIU, BRIAN C-H | UNIVERSITY OF CHICAGO | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2023 | R61 | CA278398 | RFA-CA-22-001 | GAO, XIAOJING J | STANFORD UNIVERSITY | Program the Immune System against RAS-driven Cancer | Active |
2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2023 | R33 | CA272271 | RFA-CA-22-002 | CUNNINGHAM, BRIAN T | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy | Active |
2022 | R21 | CA272345 | RFA-CA-21-003 | KNOWLES, DAVID ARTHUR | NEW YORK GENOME CENTER | A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | Active |
2021 | R21 | CA251043 | CA20-017 | HOSHIKA, SHUICHI | FOUNDATION FOR APPLIED MOLECULAR EVOLUTN | High Quality Proteins with Multiple Post Translational Modifications | Active |
2020 | R21 | CA251042 | RFA-CA-19-021 | GUPTA, GAUTAM | UNIVERSITY OF LOUISVILLE | Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens | Active |
2023 | R33 | CA278469 | RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY | Single cell modeling of cancer mutations | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R33 | CA281602 | RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors | Active |
2009 | R43 | CA137737 | RFA-CA-08-011 | ZWICK, MICHAEL G | ANDROBIOSYS, INC. | PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU | Complete |
2013 | R33 | CA173264 | RFA-CA-12-003 | TACKETT, ALAN JACKSON | UNIV OF ARKANSAS FOR MED SCIS | DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION | Complete |
2016 | R33 | CA196445 | RFA-CA-15-003 | LAM, KIT S | UNIVERSITY OF CALIFORNIA AT DAVIS | GESI: a novel technology for functional imaging in living cells | Complete |
2020 | R33 | CA236670 | RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH | Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways | Complete |
2000 | R43 | CA081787 | PAR-99-101 | BUTT, TAUSEEF R. | LIFESENSORS, INC. | LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER | Complete |
2002 | R43 | CA096056 | PAR-01-105 | STRAUME, TORE | GENMETRIX, LLC | ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES | Complete |
2006 | R21 | CA122890 | RFA-CA-06-003 | HAAB, BRIAN B. | VAN ANDEL RESEARCH INSTITUTE | DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER | Complete |